VIEMED HEALTHCARE INC (VMD) Stock Fundamental Analysis
USA - NASDAQ:VMD - CA92663R1055 - Common Stock
6.69 USD
-0.07 (-1.04%)
6.55 USD
-0.14 (-2.09%)
Taking everything into account, VMD scores 6 out of 10 in our fundamental rating. VMD was compared to 101 industry peers in the Health Care Providers & Services industry. While VMD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. VMD is not priced too expensively while it is growing strongly. Keep and eye on this one! This makes VMD very considerable for growth investing!
1. Profitability
1.1 Basic Checks
VMD had positive earnings in the past year.
VMD had a positive operating cash flow in the past year.
Each year in the past 5 years VMD has been profitable.
VMD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 7.57%, VMD belongs to the top of the industry, outperforming 90.10% of the companies in the same industry.
The Return On Equity of VMD (10.00%) is better than 73.27% of its industry peers.
VMD has a better Return On Invested Capital (7.91%) than 74.26% of its industry peers.
VMD had an Average Return On Invested Capital over the past 3 years of 7.66%. This is in line with the industry average of 9.19%.
The 3 year average ROIC (7.66%) for VMD is below the current ROIC(7.91%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.57% | ||
| ROE | 10% | ||
| ROIC | 7.91% |
ROA(3y)6.09%
ROA(5y)10.79%
ROE(3y)7.98%
ROE(5y)14.42%
ROIC(3y)7.66%
ROIC(5y)10.17%
1.3 Margins
VMD has a better Profit Margin (5.80%) than 82.18% of its industry peers.
In the last couple of years the Profit Margin of VMD has declined.
The Operating Margin of VMD (6.82%) is better than 68.32% of its industry peers.
VMD's Operating Margin has declined in the last couple of years.
VMD has a better Gross Margin (58.33%) than 80.20% of its industry peers.
VMD's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.82% | ||
| PM (TTM) | 5.8% | ||
| GM | 58.33% |
OM growth 3Y-11.38%
OM growth 5Y-8.84%
PM growth 3Y-13.54%
PM growth 5Y-13.85%
GM growth 3Y-1.78%
GM growth 5Y-3.16%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VMD is destroying value.
VMD has more shares outstanding than it did 1 year ago.
The number of shares outstanding for VMD has been increased compared to 5 years ago.
The debt/assets ratio for VMD has been reduced compared to a year ago.
2.2 Solvency
VMD has an Altman-Z score of 5.90. This indicates that VMD is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of VMD (5.90) is better than 86.14% of its industry peers.
VMD has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of VMD (0.02) is better than 82.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 5.9 |
ROIC/WACC0.9
WACC8.76%
2.3 Liquidity
A Current Ratio of 1.48 indicates that VMD should not have too much problems paying its short term obligations.
VMD has a Current ratio of 1.48. This is comparable to the rest of the industry: VMD outperforms 48.51% of its industry peers.
VMD has a Quick Ratio of 1.37. This is a normal value and indicates that VMD is financially healthy and should not expect problems in meeting its short term obligations.
VMD's Quick ratio of 1.37 is in line compared to the rest of the industry. VMD outperforms 50.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.48 | ||
| Quick Ratio | 1.37 |
3. Growth
3.1 Past
VMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 41.67%, which is quite impressive.
The Earnings Per Share has been growing slightly by 4.01% on average over the past years.
VMD shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.11%.
Measured over the past years, VMD shows a very strong growth in Revenue. The Revenue has been growing by 22.80% on average per year.
EPS 1Y (TTM)41.67%
EPS 3Y8.37%
EPS 5Y4.01%
EPS Q2Q%100%
Revenue 1Y (TTM)17.11%
Revenue growth 3Y24.18%
Revenue growth 5Y22.8%
Sales Q2Q%14.72%
3.2 Future
VMD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.89% yearly.
VMD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.73% yearly.
EPS Next Y31.06%
EPS Next 2Y32.27%
EPS Next 3Y24.89%
EPS Next 5YN/A
Revenue Next Year18.33%
Revenue Next 2Y17.92%
Revenue Next 3Y17.73%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
VMD is valuated rather expensively with a Price/Earnings ratio of 19.68.
Compared to the rest of the industry, the Price/Earnings ratio of VMD indicates a somewhat cheap valuation: VMD is cheaper than 70.30% of the companies listed in the same industry.
VMD is valuated rather cheaply when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 13.66, the valuation of VMD can be described as correct.
Based on the Price/Forward Earnings ratio, VMD is valued cheaply inside the industry as 80.20% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of VMD to the average of the S&P500 Index (22.71), we can say VMD is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.68 | ||
| Fwd PE | 13.66 |
4.2 Price Multiples
91.09% of the companies in the same industry are more expensive than VMD, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 5.71 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
VMD has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as VMD's earnings are expected to grow with 24.89% in the coming years.
PEG (NY)0.63
PEG (5Y)4.9
EPS Next 2Y32.27%
EPS Next 3Y24.89%
5. Dividend
5.1 Amount
VMD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
6.69
-0.07 (-1.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners65.63%
Inst Owner ChangeN/A
Ins Owners12.97%
Ins Owner Change1%
Market Cap259.51M
Analysts80
Price Target13.94 (108.37%)
Short Float %1.24%
Short Ratio1.58
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.99%
Min EPS beat(2)-0.99%
Max EPS beat(2)-0.99%
EPS beat(4)1
Avg EPS beat(4)6.08%
Min EPS beat(4)-5.7%
Max EPS beat(4)32.01%
EPS beat(8)1
Avg EPS beat(8)-11.48%
EPS beat(12)3
Avg EPS beat(12)-7.67%
EPS beat(16)4
Avg EPS beat(16)-7.02%
Revenue beat(2)0
Avg Revenue beat(2)-2.23%
Min Revenue beat(2)-3.39%
Max Revenue beat(2)-1.06%
Revenue beat(4)2
Avg Revenue beat(4)-0.93%
Min Revenue beat(4)-3.39%
Max Revenue beat(4)0.49%
Revenue beat(8)5
Avg Revenue beat(8)-0.39%
Revenue beat(12)8
Avg Revenue beat(12)0.05%
Revenue beat(16)12
Avg Revenue beat(16)0.96%
PT rev (1m)5.13%
PT rev (3m)5.13%
EPS NQ rev (1m)-5%
EPS NQ rev (3m)-5%
EPS NY rev (1m)-1.8%
EPS NY rev (3m)-1.8%
Revenue NQ rev (1m)4.14%
Revenue NQ rev (3m)4.14%
Revenue NY rev (1m)1.59%
Revenue NY rev (3m)1.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.68 | ||
| Fwd PE | 13.66 | ||
| P/S | 1.08 | ||
| P/FCF | N/A | ||
| P/OCF | 6.06 | ||
| P/B | 1.86 | ||
| P/tB | 2.45 | ||
| EV/EBITDA | 5.71 |
EPS(TTM)0.34
EY5.08%
EPS(NY)0.49
Fwd EY7.32%
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)1.1
OCFY16.51%
SpS6.21
BVpS3.6
TBVpS2.73
PEG (NY)0.63
PEG (5Y)4.9
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.57% | ||
| ROE | 10% | ||
| ROCE | 11.16% | ||
| ROIC | 7.91% | ||
| ROICexc | 9.15% | ||
| ROICexgc | 12.45% | ||
| OM | 6.82% | ||
| PM (TTM) | 5.8% | ||
| GM | 58.33% | ||
| FCFM | N/A |
ROA(3y)6.09%
ROA(5y)10.79%
ROE(3y)7.98%
ROE(5y)14.42%
ROIC(3y)7.66%
ROIC(5y)10.17%
ROICexc(3y)8.81%
ROICexc(5y)13.58%
ROICexgc(3y)11.22%
ROICexgc(5y)15.03%
ROCE(3y)10.8%
ROCE(5y)14.35%
ROICexcg growth 3Y2.65%
ROICexcg growth 5Y-2.94%
ROICexc growth 3Y-7.87%
ROICexc growth 5Y-9.04%
OM growth 3Y-11.38%
OM growth 5Y-8.84%
PM growth 3Y-13.54%
PM growth 5Y-13.85%
GM growth 3Y-1.78%
GM growth 5Y-3.16%
F-Score8
Asset Turnover1.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.08 | ||
| Cap/Depr | 176.74% | ||
| Cap/Sales | 19.28% | ||
| Interest Coverage | 25.41 | ||
| Cash Conversion | 100.29% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.48 | ||
| Quick Ratio | 1.37 | ||
| Altman-Z | 5.9 |
F-Score8
WACC8.76%
ROIC/WACC0.9
Cap/Depr(3y)138.25%
Cap/Depr(5y)145.08%
Cap/Sales(3y)15.87%
Cap/Sales(5y)14.88%
Profit Quality(3y)92.19%
Profit Quality(5y)75.37%
High Growth Momentum
Growth
EPS 1Y (TTM)41.67%
EPS 3Y8.37%
EPS 5Y4.01%
EPS Q2Q%100%
EPS Next Y31.06%
EPS Next 2Y32.27%
EPS Next 3Y24.89%
EPS Next 5YN/A
Revenue 1Y (TTM)17.11%
Revenue growth 3Y24.18%
Revenue growth 5Y22.8%
Sales Q2Q%14.72%
Revenue Next Year18.33%
Revenue Next 2Y17.92%
Revenue Next 3Y17.73%
Revenue Next 5YN/A
EBIT growth 1Y5.79%
EBIT growth 3Y10.05%
EBIT growth 5Y11.94%
EBIT Next Year209.91%
EBIT Next 3Y61.39%
EBIT Next 5YN/A
FCF growth 1Y-132.43%
FCF growth 3Y-21.74%
FCF growth 5Y-25.39%
OCF growth 1Y26.82%
OCF growth 3Y20.23%
OCF growth 5Y15.41%